Inivata ‘liquid biopsy’ technology company first lifescience investment for CIC fund
A new technique that allows information about a cancer tumour to be gained quickly from a blood test is a step closer to being used by clinicians. The technology is to be brought to market by Inivata, a new spinout from Cancer Research UK following investment of £4million from Cambridge Innovation Capital, Imperial Innovations and Johnson & Johnson Development Corporation.
CIC announces first three investments from its £50 million Cambridge Cluster Fund
Cambridge Innovation Capital (CIC), an investor in high-growth technology companies in the Cambridge cluster, has completed its first investments from a £50 million fund, backing three companies that address rapidly growing market opportunities in the areas of cloud-based video archiving, grid-scale energy management and generative music composition.
£50 million of long-term capital to support Cambridge technology companies
Intelligent, patient capital to bring innovative technologies to market